Showing results (2031-2040 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|June 5, 2020
Management of Sleep Disturbances Associated with Smith-Magenis SyndromeKevin A Kaplan, Sarah H Elsea, Lorraine PotockiCNS Drugs|August 9, 2021
Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in SpainJuan C Pascual, Ana Martín-Blanco, Joaquim SolerCNS Drugs|August 9, 2021
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple SclerosisAmit Bar-Or, Susan M O'Brien, Michael L Sweeney, et al.CNS Drugs|September 8, 2021
Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-AnalysisGerald Gartlehner, Karen Crotty, Sara Kennedy, et al.CNS Drugs|November 17, 2022
A Multicenter, Randomized, Double-Blind, Positive-Controlled, Non-Inferiority, Phase III Clinical Trial Evaluating the Efficacy and Safety of Emulsified Isoflurane for Anesthesia Induction in PatientsHui Yang, YuJun Zhang, ChuiLiang Liu, et al.CNS Drugs|February 13, 2023
Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label StudyJai Perumal, Roumen Balabanov, Ray Su, et al.CNS Drugs|May 31, 2020
Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's DiseaseClaire Henchcliffe, Harini SarvaCNS Drugs|June 24, 2020
Application of Healthcare 'Big Data' in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)Jenni Ilomäki, J Simon Bell, Adrienne Y L Chan, et al.CNS Drugs|August 18, 2016
A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to MethylphenidateEvelina A Zimovetz, Stephen M Beard, Paul Hodgkins, et al.CNS Drugs|April 20, 2020
Predicted Cellular and Molecular Actions of Lithium in the Treatment of Bipolar Disorder: An In Silico StudyHadi Najafi, Mehdi Totonchi, Majid SadeghizadehPageof 211